Abstract:Liver cirrhosis is a predominant risk factor for hepatocellular carcinoma (HCC). However, the mechanism underlying the progression from cirrhosis to HCC remains unclear. Herein we report the concurrent increase of liver progenitor cells (LPCs) and transforming growth factor-beta (TGF-beta) in diethylnitrosamine (DEN)-induced rat hepatocarcinogenesis and cirrhotic livers of HCC patients. Using several experimental approaches, including 2-acetylaminofluorene/partial hepatectomy (2-AAF/PHx) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-elicited murine liver regeneration, we found that activation of LPCs in the absence of TGF-beta induction was insufficient to trigger hepatocarcinogenesis. Moreover, a small fraction of LPCs was detected to coexpress tumor initiating cell (T-IC) markers during rat hepatocarcinogenesis and in human HCCs, and TGF-beta levels were positively correlated with T-IC marker expression, which indicates a role of TGF-beta in T-IC generation. Rat pluripotent LPC-like WB-F344 cells were exposed to low doses of TGF-beta for 18 weeks imitating the enhanced TGF-beta expression in cirrhotic liver. Interestingly, long-term treatment of TGF-beta on WB-F344 cells impaired their LPC potential but granted them T-IC properties including expression of T-IC markers, increased self-renewal capacity, stronger chemoresistance, and tumorigenicity in NOD-SCID mice. Hyperactivation of Akt but not Notch, signal transducer and activator of transcription 3 (STAT3), or mammalian target of rapamycin (mTOR) was detected in TGF-beta-treated WB-F344 cells. Introduction of the dominant-negative mutant of Akt significantly attenuated T-IC properties of those transformed WB-F344 cells, indicating Akt was required in TGF-beta-mediated-generation of hepatic T-ICs. We further demonstrate that TGF-beta-induced Akt activation and LPC transformation was mediated by microRNA-216a-modulated phosphatase and tensin homolog deleted on chromosome 10 (PTEN) suppression. Conclusion: Hepatoma-initiating cells may derive from hepatic progenitor cells exposed to chronic and constant TGF-beta stimulation in cirrhotic liver, and pharmaceutical inhibition of microRNA-216a/PTEN/Akt signaling could be a novel strategy for HCC prevention and therapy targeting hepatic T-ICs. (HEPATOLOGY 2012;56:2255-2267)

Regulation of a TGF-β1-CD147 Self-Sustaining Network in the Differentiation Plasticity of Hepatocellular Carcinoma Cells

Infiltrating Regulatory T Cells Promote Invasiveness of Liver Cancer Cells Via Inducing Epithelial-Mesenchymal Transition

Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis

Cluster of Differentiation 147 is A Key Molecule During Hepatocellular Carcinoma Cell-Hepatic Stellate Cell Cross-Talk in the Rat Liver

Tumor and Stem Cell Biology BMP 4 Administration Induces Differentiation of CD 133 þ Hepatic Cancer Stem Cells , Blocking Their Contributions to Hepatocellular Carcinoma

HAb18G/CD147 promotes epithelial–mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug

TGF-β Combined with EGFR Inhibitor Induce HCC Trans-Differentiation into Fibroblasts Via Epithelial-Mesenchymal Transition

Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications.

CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis.

Differentiation therapy: Unlocking phenotypic plasticity of hepatocellular carcinoma

Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression Through Activation of Hepatocyte Nuclear Factor-6.

Β2 Spectrin-Mediated Differentiation Repressed the Properties of Liver Cancer Stem Cells Through Β-Catenin.

CXCR7 Correlates with the Differentiation of Hepatocellular Carcinoma and Suppresses HNF4α Expression Through the ERK Pathway.

HAb18G/CD147 is Involved in TGF‐β‐induced Epithelial‐mesenchymal Transition and Hepatocellular Carcinoma Invasion

Downregulation of Cd147 Expression Alters Cytoskeleton Architecture and Inhibits Gelatinase Production and Sapk Pathway in Human Hepatocellular Carcinoma Cells

Contextual Regulation of TGF-β Signaling in Liver Cancer

Data from HAb18G/CD147 Promotes Radioresistance in Hepatocellular Carcinoma Cells: A Potential Role for Integrin Β1 Signaling

Gamma-secretase Complex-Dependent Intramembrane Proteolysis of CD147 Regulates the Notch1 Signaling Pathway in Hepatocellular Carcinoma

Double-negative Feedback Loop Between Wnt/β-catenin Signaling and HNF4α Regulates Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization.

Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.